Case report: A 50 year‐old Down syndrome man exhibiting no Alzheimer’s disease biomarker profile nor cognitive impairment. Experience from the Argentine Initiative for the Study of Down syndrome and Alzheimer’s

Abstract Background Down Syndrome (DS) is the most common genetic form of intellectual disability. In recent years, there has been a significant increase in the life expectancy of individuals with DS, currently reaching the age of 60 or over. However, it has been observed that as of age 40, these individuals experience higher risk of developing dementia, and almost all of them exhibit histopathological characteristics of Alzheimer's disease (AD) in their brains. As part of the first Latin American initiative for the study of Alzheimer’s disease in adults with Down syndrome (IASDA), we recruited a 50‐year‐old participant identified as SD8, who did not exhibit beta‐amyloid brain deposition and showed no signs of cognitive impairment. Method The absence of beta‐amyloid brain deposition was determined by positron‐emission tomography (PET) using an amyloid‐binding compound (PiB) and quantification of cerebrospinal fluid biomarkers. To explore the possibility that lack of Aβ deposition could be due to an interstitial deletion of the APP gene, we performed Array‐CGH and MLPA assays. Additionally, an exome analysis was conducted to assess the presence of Alzheimer's protective gene variants. Induced pluripotent stem cells (iPSCs) were generated from SD8 peripheral blood mononuclear cells and subsequently differentiated into neurons. This approach will enable a more in‐depth study to gain further insights into this case. Result These investigations revealed that SD8 possessed three copies of the APP gene, thus eliminating the possibility of an interstitial deletion. However, the exome analysis yielded no significant findings. Conclusion In summary, in this study we present the strategies employed to delve into the possible mechanisms of SD8 being an AD “escapee” and outline our planned steps for further investigation.

Authors

Institutions

Publication Details

Journal
Alzheimer s & Dementia
Published
2024-12-01
DOI
https://doi.org/10.1002/alz.086949
Primary Topic
Down syndrome and intellectual disability research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Case report: A 50 year‐old Down syndrome man exhibiting no Alzheimer’s disease biomarker profile nor cognitive impairment. Experience from the Argentine Initiative for the Study of Down syndrome and Alzheimer’s

Ezequiel Surace, Leonardo Romorini, Lucía Pertierra, Giulia Solange Clas et al.
Alzheimer s & Dementia
Down syndrome and intellectual disability research
article

Case report: A 50 year‐old Down syndrome man exhibiting no Alzheimer’s disease biomarker profile nor cognitive impairment. Experience from the Argentine Initiative for the Study of Down syndrome and Alzheimer’s

Ezequiel Surace, Leonardo Romorini, Lucía Pertierra, Giulia Solange Clas, Belén Helou, Ricardo Allegri, Mariela C. Marazita, Fernanda Tapajóz, Nahuel Magrath Guimet
article en

Abstract

Abstract Background Down Syndrome (DS) is the most common genetic form of intellectual disability. In recent years, there has been a significant increase in the life expectancy of individuals with DS, currently reaching the age of 60 or over. However, it has been observed that as of age 40, these individuals experience higher risk of developing dementia, and almost all of them exhibit histopathological characteristics of Alzheimer's disease (AD) in their brains. As part of the first Latin American initiative for the study of Alzheimer’s disease in adults with Down syndrome (IASDA), we recruited a 50‐year‐old participant identified as SD8, who did not exhibit beta‐amyloid brain deposition and showed no signs of cognitive impairment. Method The absence of beta‐amyloid brain deposition was determined by positron‐emission tomography (PET) using an amyloid‐binding compound (PiB) and quantification of cerebrospinal fluid biomarkers. To explore the possibility that lack of Aβ deposition could be due to an interstitial deletion of the APP gene, we performed Array‐CGH and MLPA assays. Additionally, an exome analysis was conducted to assess the presence of Alzheimer's protective gene variants. Induced pluripotent stem cells (iPSCs) were generated from SD8 peripheral blood mononuclear cells and subsequently differentiated into neurons. This approach will enable a more in‐depth study to gain further insights into this case. Result These investigations revealed that SD8 possessed three copies of the APP gene, thus eliminating the possibility of an interstitial deletion. However, the exome analysis yielded no significant findings. Conclusion In summary, in this study we present the strategies employed to delve into the possible mechanisms of SD8 being an AD “escapee” and outline our planned steps for further investigation.

Alzheimer s & DementiaVol. 20(S2)
Fundación para la Lucha contra las Enfermedades Neurológicas de la Infancia (AR)
Openalex Percentile: Top 62%
Down syndrome and intellectual disability research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.